Credit Suisse’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-2,938
| Closed | -$18K | – | 2977 |
|
|
2023
Q4 | $18K | Hold |
2,938
| – | – | ﹤0.01% | 3038 |
|
|
2023
Q3 | $13.7K | Sell |
2,938
-1,812
| -38% | -$8.46K | ﹤0.01% | 3120 |
|
|
2023
Q2 | $25.5K | Sell |
4,750
-25,627
| -84% | -$137K | ﹤0.01% | 3139 |
|
|
2023
Q1 | $299K | Buy |
30,377
+4,971
| +20% | +$48.9K | ﹤0.01% | 2980 |
|
|
2022
Q4 | $476K | Buy |
25,406
+6,421
| +34% | +$120K | ﹤0.01% | 2801 |
|
|
2022
Q3 | $393K | Buy |
18,985
+309
| +2% | +$6.4K | ﹤0.01% | 2918 |
|
|
2022
Q2 | $388K | Sell |
18,676
-9,399
| -33% | -$195K | ﹤0.01% | 2986 |
|
|
2022
Q1 | $1.21M | Buy |
28,075
+463
| +2% | +$19.9K | ﹤0.01% | 2406 |
|
|
2021
Q4 | $1.65M | Buy |
27,612
+1,016
| +4% | +$60.9K | ﹤0.01% | 2269 |
|
|
2021
Q3 | $2.28M | Sell |
26,596
-17,466
| -40% | -$1.5M | ﹤0.01% | 2070 |
|
|
2021
Q2 | $4.9M | Buy |
44,062
+8,696
| +25% | +$967K | ﹤0.01% | 1555 |
|
|
2021
Q1 | $3.94M | Sell |
35,366
-2,883
| -8% | -$321K | ﹤0.01% | 1699 |
|
|
2020
Q4 | $4.06M | Buy |
38,249
+13,762
| +56% | +$1.46M | ﹤0.01% | 1670 |
|
|
2020
Q3 | $3.41M | Sell |
24,487
-1,470
| -6% | -$205K | ﹤0.01% | 1490 |
|
|
2020
Q2 | $8.39M | Buy |
25,957
+22,300
| +610% | +$7.21M | 0.01% | 1069 |
|
|
2020
Q1 | $327K | Sell |
3,657
-258
| -7% | -$23.1K | ﹤0.01% | 2775 |
|
|
2019
Q4 | $156K | Sell |
3,915
-3,138
| -44% | -$125K | ﹤0.01% | 3359 |
|
|
2019
Q3 | $174K | Buy |
7,053
+1,877
| +36% | +$46.3K | ﹤0.01% | 3221 |
|
|
2019
Q2 | $182K | Buy |
5,176
+210
| +4% | +$7.38K | ﹤0.01% | 3224 |
|
|
2019
Q1 | $223K | Buy |
4,966
+998
| +25% | +$44.8K | ﹤0.01% | 3140 |
|
|
2018
Q4 | $190K | Sell |
3,968
-2,913
| -42% | -$139K | ﹤0.01% | 3148 |
|
|
2018
Q3 | $459K | Buy |
6,881
+748
| +12% | +$49.9K | ﹤0.01% | 2886 |
|
|
2018
Q2 | $288K | Sell |
6,133
-1,915
| -24% | -$89.9K | ﹤0.01% | 3181 |
|
|
2018
Q1 | $455K | Buy |
8,048
+1,272
| +19% | +$71.9K | ﹤0.01% | 2989 |
|
|
2017
Q4 | $337K | Sell |
6,776
-1,537
| -18% | -$76.4K | ﹤0.01% | 3095 |
|
|
2017
Q3 | $632K | Buy |
8,313
+2,971
| +56% | +$226K | ﹤0.01% | 2941 |
|
|
2017
Q2 | $502K | Sell |
5,342
-5,715
| -52% | -$537K | ﹤0.01% | 2779 |
|
|
2017
Q1 | $879K | Buy |
11,057
+5,755
| +109% | +$458K | ﹤0.01% | 2611 |
|
|
2016
Q4 | $442K | Sell |
5,302
-1,525
| -22% | -$127K | ﹤0.01% | 3148 |
|
|
2016
Q3 | $763K | Sell |
6,827
-2,368
| -26% | -$265K | ﹤0.01% | 2844 |
|
|
2016
Q2 | $1.02M | Buy |
9,195
+8
| +0.1% | +$887 | ﹤0.01% | 2635 |
|
|
2016
Q1 | $960K | Buy |
9,187
+3,835
| +72% | +$401K | ﹤0.01% | 2481 |
|
|
2015
Q4 | $432K | Sell |
5,352
-8,704
| -62% | -$703K | ﹤0.01% | 3266 |
|
|
2015
Q3 | $974K | Buy |
14,056
+1,722
| +14% | +$119K | ﹤0.01% | 2664 |
|
|
2015
Q2 | $1.21M | Buy |
12,334
+8,484
| +220% | +$831K | ﹤0.01% | 2752 |
|
|
2015
Q1 | $377K | Sell |
3,850
-6,049
| -61% | -$592K | ﹤0.01% | 3461 |
|
|
2014
Q4 | $1.09M | Buy |
9,899
+1,548
| +19% | +$171K | ﹤0.01% | 2733 |
|
|
2014
Q3 | $988K | Buy |
8,351
+1,037
| +14% | +$123K | ﹤0.01% | 2689 |
|
|
2014
Q2 | $949K | Sell |
7,314
-339
| -4% | -$44K | ﹤0.01% | 2934 |
|
|
2014
Q1 | $1.22M | Buy |
7,653
+6,018
| +368% | +$962K | ﹤0.01% | 2624 |
|
|
2013
Q4 | $227K | Buy |
+1,635
| New | +$227K | ﹤0.01% | 3814 |
|